C79.1
Secondary malignant neoplasm of bladder and other and unspecified urinary organs
Clinical Classification Guidelines
Medical Intelligence & Overview
Secondary malignant neoplasm of the bladder, classified under ICD-10 code C79.1, refers to cancer that has spread to the bladder from a primary tumor located elsewhere in the body. This condition is a type of metastatic cancer, indicating that cancer cells have traveled from their original site to establish a secondary tumor in the bladder or other urinary organs. Recognizing this condition is crucial for determining appropriate treatment strategies and understanding the prognosis. It often presents in patients who have a history of primary cancer elsewhere, and its management generally involves a multidisciplinary medical approach.
Causes & Symptoms
Clinical Causes: Spread of primary cancer from other organs such as the prostate, colon, rectum, or uterus. Metastasis from distant sites like the lungs, breast, or skin (melanoma). Direct extension of nearby cancers, for example, from reproductive organs or the reproductive tract. Bloodstream or lymphatic system dissemination of malignant cells from primary tumors.
Key Symptoms: Blood in the urine (hematuria) Pain or discomfort in the lower abdomen or pelvis Urinary urgency or frequency Pain during urination Unexplained weight loss General fatigue and weakness Signs of metastatic disease such as persistent cough or bone pain, depending on the primary cancer site
Diagnostic & Treatment
Diagnosis Path: Urinalysis to detect blood or abnormal cells in the urine Imaging modalities such as CT scans, MRI, or PET scans to identify primary and secondary tumor sites Cystoscopy, allowing direct visualization of the bladder interior and collection of biopsy samples Histopathological examination of tissue biopsies to determine the cancer type Immunohistochemistry and other molecular tests to trace the primary tumor origin
Treatment Protocols: Systemic therapies such as chemotherapy, targeted therapy, or immunotherapy aimed at controlling metastatic disease Surgical intervention may be considered to remove or reduce tumor burden in the bladder or other affected organs Radiation therapy to relieve symptoms or control localized metastatic lesions Supportive and palliative care to improve quality of life, manage pain, and address symptoms
Clinical Advice & FAQs
Billing Guidance
Is C79.1 a billable ICD-10 code?
Yes, C79.1 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report C79.1?
Clinical documentation must specify the nature of Secondary malignant neoplasm of bladder and other and unspecified urinary organs and any associated comorbidities for accurate reporting.
Cite this Clinical Reference